Amneal Pharmaceuticals, Inc.
AMRX
$11.95
-$0.17-1.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.08M | 2.37M | 22.42M | 12.20M | -31.08M |
| Total Depreciation and Amortization | 49.23M | 54.07M | 60.11M | 60.16M | 66.13M |
| Total Amortization of Deferred Charges | 3.72M | 5.03M | 6.88M | 6.81M | 6.82M |
| Total Other Non-Cash Items | 54.59M | 107.72M | 29.52M | 34.62M | 54.36M |
| Change in Net Operating Assets | -12.29M | -50.74M | -35.11M | -106.38M | 21.86M |
| Cash from Operations | 130.32M | 118.45M | 83.82M | 7.41M | 118.08M |
| Capital Expenditure | -43.17M | -15.05M | -26.50M | -14.12M | -22.46M |
| Sale of Property, Plant, and Equipment | 715.00K | 0.00 | 855.00K | 524.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 7.01M |
| Other Investing Activities | -3.00M | -7.41M | -900.00K | -4.20M | -600.00K |
| Cash from Investing | -45.45M | -22.46M | -26.55M | -17.80M | -16.06M |
| Total Debt Issued | 795.00K | 2.70B | 0.00 | 218.00M | 0.00 |
| Total Debt Repaid | -6.12M | -2.55B | -15.55M | -235.53M | -55.54M |
| Issuance of Common Stock | 553.00K | 653.00K | 685.00K | 69.00K | 151.00K |
| Repurchase of Common Stock | -321.00K | -129.00K | -189.00K | -21.64M | -387.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.02M | -87.10M | -26.64M | -68.00K | -5.43M |
| Cash from Financing | -10.12M | 59.44M | -41.69M | -39.17M | -61.20M |
| Foreign Exchange rate Adjustments | -209.00K | -694.00K | -307.00K | -470.00K | -740.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.53M | 154.74M | 15.28M | -50.03M | 40.08M |